Wickes Group plc (WIX.L)
GBp 180.0
(0.9%)
GBp 180.0
(0.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 185.5 Million | 125.7 Million | 101.4 Million | 76.8 Million | 108.5 Million | 176.8 Million |
| Net Income | 29.8 Million | 67.1 Million | 96.7 Million | 61 Million | 56.2 Million | 56.6 Million |
| Depreciation & Amortization | 101.9 Million | 103 Million | 102.4 Million | 103.1 Million | 106 Million | 108.2 Million |
| Deferred income taxes | -208.5 Million | - | - | - | - | -41.7 Million |
| Stock-based compensation | 5.6 Million | 4.4 Million | 3.8 Million | 1.7 Million | 2 Million | 1.5 Million |
| Change in working capital | 2.6 Million | -28.7 Million | -56.2 Million | -51.4 Million | -17.1 Million | 53.7 Million |
| Other non-cash items | 254.1 Million | -20.1 Million | -45.3 Million | -37.6 Million | -38.6 Million | -1.5 Million |
| Investing Cash Flow | -38.1 Million | -38.1 Million | 98.3 Million | -19.9 Million | -24.1 Million | -41.3 Million |
| Investments in PPE | -38.2 Million | -40.4 Million | -26.5 Million | -20.1 Million | -24.1 Million | -43.8 Million |
| Acquisitions | 100 Thousand | 400 Thousand | 1.2 Million | 200 Thousand | - | 2.5 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.2 Million | 1.9 Million | 123.6 Million | -137.1 Million | -4.5 Million | 2.5 Million |
| Financing Cash Flow | -149.4 Million | -111.5 Million | -82.8 Million | -75.8 Million | -75.2 Million | -125.9 Million |
| Debt repayment | -84.3 Million | -82.4 Million | -77.8 Million | -75.8 Million | -75.2 Million | -75.2 Million |
| Dividends payments | -27.4 Million | -31.2 Million | -5.3 Million | - | - | -50.7 Million |
| Common Stock Repurchased | -10.3 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -111.7 Million | 2.1 Million | 300 Thousand | -75.8 Million | -75.2 Million | -75.2 Million |
| Accounts receivables | 13.4 Million | -9.9 Million | -7.4 Million | -107.3 Million | 412.1 Million | -27.2 Million |
| Accounts payables | -18.6 Million | -4.09 Million | -700 Thousand | 43.8 Million | -426.6 Million | 76.2 Million |
| Inventory | 6.1 Million | -13.4 Million | -49.9 Million | 12.1 Million | -2.6 Million | 4.7 Million |
| Other working capital | 1.7 Million | -1.3 Million | 1.8 Million | -2.9 Million | - | 49 Million |
| Cash at beginning of period | 99.5 Million | 123.4 Million | 6.5 Million | 25.4 Million | 16.2 Million | 6.6 Million |
| Cash at end of period | 97.5 Million | 99.5 Million | 123.4 Million | 6.5 Million | 25.4 Million | 16.2 Million |
| Capital Expenditure | -38.2 Million | -40.4 Million | -26.5 Million | -20.1 Million | -24.1 Million | -43.8 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2 Million | -23.9 Million | 116.9 Million | -18.9 Million | 9.2 Million | 9.6 Million |
| Free Cash Flow | 147.3 Million | 85.3 Million | 74.9 Million | 56.7 Million | 84.4 Million | 133 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.45 Million | 8.45 Million | 29.8 Million | 6.9 Million | 6.9 Million | 16 Million |
| Depreciation & Amortization | 26.3 Million | 26.3 Million | 101.9 Million | 24.1 Million | 24.1 Million | 50.3 Million |
| Deferred income taxes | - | - | -208.5 Million | -189.15 Million | - | -16.7 Million |
| Stock-based compensation | 1.05 Million | 1.05 Million | 5.6 Million | 1.65 Million | 1.65 Million | 1.3 Million |
| Change in working capital | -1.25 Million | -1.25 Million | 2.6 Million | 4.85 Million | 4.85 Million | 87 Million |
| Other non-cash items | 40.1 Million | 40.1 Million | 254.1 Million | -36.8 Million | -36.8 Million | 42.9 Million |
| Investing Cash Flow | -5.35 Million | -5.35 Million | -38.1 Million | -10 Million | -10 Million | -14.3 Million |
| Investments in PPE | -5.2 Million | -5.2 Million | -38.2 Million | -10.3 Million | -10.3 Million | -14.3 Million |
| Acquisitions | -1.15 Million | -1.15 Million | 100 Thousand | 100 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1 Million | 1 Million | 1.2 Million | 300 Thousand | 300 Thousand | 300 Thousand |
| Financing Cash Flow | -41.85 Million | -41.85 Million | -149.4 Million | -36.95 Million | -36.95 Million | -76 Million |
| Debt repayment | - | - | -84.3 Million | - | - | - |
| Dividends payments | -8.8 Million | -8.8 Million | -27.4 Million | -4.5 Million | -4.5 Million | -18.4 Million |
| Common Stock Repurchased | -5.65 Million | -5.65 Million | -10.3 Million | -5.05 Million | -5.05 Million | -200 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -27.4 Million | -27.4 Million | -111.7 Million | -27.4 Million | -27.4 Million | 400 Thousand |
| Accounts receivables | -1.85 Million | -1.85 Million | 13.4 Million | 1.7 Million | 1.7 Million | 10 Million |
| Accounts payables | 67.4 Million | - | -18.6 Million | -94.1 Million | - | 75.5 Million |
| Inventory | 550 Thousand | 550 Thousand | 6.1 Million | 3.2 Million | 3.2 Million | -300 Thousand |
| Other working capital | 50 Thousand | 50 Thousand | 1.7 Million | -50 Thousand | -50 Thousand | 1.8 Million |
| Cash at beginning of period | 97.5 Million | - | 99.5 Million | 190 Million | - | 99.5 Million |
| Cash at end of period | 152.4 Million | 27.45 Million | 97.5 Million | 97.5 Million | -46.25 Million | 190 Million |
| Capital Expenditure | -5.2 Million | -5.2 Million | -38.2 Million | -10.3 Million | -10.3 Million | -14.3 Million |
| Effect of forex changes on cash | - | - | - | 1.00 | - | - |
| Net cash flow / Change in cash | 54.9 Million | 27.45 Million | -2 Million | -92.5 Million | -46.25 Million | 90.5 Million |
| Free Cash Flow | 69.45 Million | 69.45 Million | 147.3 Million | -9.6 Million | -9.6 Million | 166.5 Million |
KLIN
000875
CHCT
ARSSF
603075
PXPC